首页> 外国专利> Inhibitors for the zymogen-like liberation cleavage of HIV-1 protease

Inhibitors for the zymogen-like liberation cleavage of HIV-1 protease

机译:HIV-1蛋白酶的酶原样裂解裂解的抑制剂

摘要

Because the gag-pol dimer, which is evidently responsible for the initial proteolytic activity, has a substrate specificity which differs slightly from the mature PR (or at least different catalytic constants), conventional PR inhibitors are not able to inhibit it optimally. The aim therefore is to find inhibitors which are able to inhibit specifically the initial cuts in the gag-pol polyprotein. The inhibitors described herein are based on two amino-acid sequences which are initially cut in the gag-pol polyprotein and differ in essential positions from the cleavage sites which are cleaved by the mature HIV-1 protease. The two amino-acid sequences suitable and preferred as cleavage sites of a proteolytically active gag-pol dimer are: P4 P3 P2 P1 P1' P2' P3' Arg-Gln-Ala-Asn * Phe-Leu-Arg Asp-Leu-Ala-Phe * Pro-Gln-Gly. The following inhibitors can be derived from these: IMAGE The underlined groups are merely examples and can be replaced by groups of comparable function. Use of the inhibitors as pharmaceuticals for inhibiting the replication of HIV-1 in infected people.
机译:因为明显负责初始蛋白水解活性的gag-pol二聚体具有与成熟PR略有不同的底物特异性(或至少具有不同的催化常数),所以常规PR抑制剂无法最佳地抑制它。因此,目的是找到能够特异性抑制gag-pol多蛋白的最初切割的抑制剂。本文所述的抑制剂基于两个氨基酸序列,所述两个氨基酸序列最初在gag-pol多蛋白中被切割,并且在基本位置上与被成熟HIV-1蛋白酶切割的切割位点不同。合适并优选作为蛋白水解活性gag-pol二聚体的切割位点的两个氨基酸序列是:P4 P3 P2 P1 P1'P2'P3'Arg-Gln-Ala-Asn * Phe-Leu-Arg Asp-Leu-Ala -Phe * Pro-Gln-Gly。可以从中衍生出以下抑制剂:<图像>带下划线的基团仅是示例,可以被功能相似的基团取代。抑制剂用作抑制HIV-1在感染者中复制的药物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号